Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
TDM-180935 by Technoderma Medicines for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
TDM-180935 is under clinical development by Technoderma Medicines and currently in Phase II for Atopic Dermatitis (Atopic Eczema). According to...
Data Insights
TDM-180935 by Technoderma Medicines for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
TDM-180935 is under clinical development by Technoderma Medicines and currently in Phase II for Atopic Dermatitis (Atopic Eczema). According to...